ODA
0.115
167.4%
JDO
0.915
-40.4%
AOK
0.003
50%
FBR
0.002
-33.3%
NX1
0.018
38.5%
MFD
0.16
-33.3%
T3D
0.046
31.4%
UM1
0.1
-31%
EIQ
1.615
30.2%
M2M
0.007
-30%
DXN
0.23
27.8%
CLU
0.005
-28.6%
BSR
0.465
27.4%
ALY
0.006
-25%
DME
0.04
25%
BLU
0.003
-25%
FCT
0.01
25%
CAN
0.003
-25%
NPM
0.016
23.1%
CCR
0.15
-25%
CLA
0.006
20%
NMT
0.021
-25%
OEL
0.006
20%
TON
0.003
-25%
OSM
0.62
17%
TSK
0.065
-23.5%
MEM
0.007
16.7%
AM3
0.004
-20%
PET
0.007
16.7%
IBX
0.012
-20%
SKM
0.25
16.3%
T88
0.04
-20%
SFX
0.041
13.9%
DTM
0.013
-18.8%
PTX
0.066
13.8%
AUV
0.009
-18.2%
3PL
0.335
13.6%
INF
0.009
-18.2%
CXL
0.475
13.1%
KNG
0.045
-18.2%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AVITA Medical (ASX:AVH) signed an exclusive 5 year distribution agreement with Stedical Scientific

AVITA Medical (ASX:AVH) signed an exclusive five year distribution agreement with Stedical Scientific, to commercialise PermeaDerm® Biosynthetic Wound Matrix in the U.S. The matrix is cleared by the U.S. FDA and used for a variety of injuries | https://announcements.asx.com.au/asxpdf/20240111/pdf/05zbp446ftpyw0.pdf #FDA #PermeaDerm #AVH